Chosa Oncology AB (XSAT:CHOSA) Total Stockholders Equity: kr21.67 Mil (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

XSAT:CHOSA Chosa Oncology AB XSAT:CHOSA
32 GF Score
Price kr0.74
View Full Analysis

What is Chosa Oncology AB Total Stockholders Equity?

Chosa Oncology AB XSAT:CHOSA -2.37% 32 Total Stockholders Equity is kr21.67 Mil as of Mar. 2026. GuruFocus rates XSAT:CHOSA with a GF Score™ of 32/100.

Chosa Oncology AB's Total Stockholders Equity for the quarter that ended in Mar. 2026 was kr21.67 Mil. It refers to the net assets owned by shareholders. It does not include minority interest.

Total Stockholders Equity is used to calculate Book Value per Share. Chosa Oncology AB's Book Value per Share for the quarter that ended in Mar. 2026 was kr0.25. The ratio of a company's debt over equity can be used to measure how leveraged this company is. Chosa Oncology AB's Debt-to-Equity for the quarter that ended in Mar. 2026 was 0.00.

Chosa Oncology AB  (XSAT:CHOSA) Total Stockholders Equity Explanation

1. Total Stockholders Equity is used to calculate Book Value per Share.

Chosa Oncology AB's Book Value per Share for the quarter that ended in Mar. 2026 is

Book Value per Share=(Total Stockholders Equity-Preferred Stock)/Shares Outstanding (EOP)
=(21.673-0)/87.864
=0.25

2. The ratio of a company's debt over equity can be used to measure how leveraged this company is.

Chosa Oncology AB's Debt-to-Equity for the quarter that ended in Mar. 2026 is

Debt-to-Equity=Total Debt / Total Stockholders Equity
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / Total Stockholders Equity
=(0 + 0) / 21.673
=0.00

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Chosa Oncology AB Total Stockholders Equity Related Terms

Chosa Oncology AB Total Stockholders Equity Historical Data

* Premium members only.

The historical data trend for Chosa Oncology AB's Total Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Chosa Oncology AB Total Stockholders Equity Chart

Chosa Oncology AB Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Total Stockholders Equity
Get a 7-Day Free Trial Premium Member Only Premium Member Only 41.70 11.61 17.41 18.63 16.54

Chosa Oncology AB Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Total Stockholders Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 11.63 14.47 16.13 16.54 21.67
XSAT:CHOSA
32GF Score
Chosa Oncology AB XSAT:CHOSA
Total Stockholders Equity is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
What does a Total Stockholders Equity of kr21.67 Mil mean?
Chosa Oncology AB (XSAT:CHOSA) has a Total Stockholders Equity of kr21.67 Mil as of Mar. 2026. The total amount of shareholder's equity as recorded on a company's balance sheet. View historical data for Chosa Oncology AB and its competitors.
Is Chosa Oncology AB's Total Stockholders Equity too high?
Chosa Oncology AB's current Total Stockholders Equity is kr21.67 Mil. Overall, Chosa Oncology AB has a GF Score™ of 32/100, reflecting its overall financial health beyond just this single metric.
How does Chosa Oncology AB's Total Stockholders Equity compare to VRTX and REGN?
Chosa Oncology AB's Total Stockholders Equity of kr21.67 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Stockholders Equity for a Biotechnology company?
A good Total Stockholders Equity depends on the Biotechnology industry context. However, Total Stockholders Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Stockholders Equity mean?
A high Total Stockholders Equity can signal that a stock is expensive relative to its fundamentals. The total amount of shareholder's equity as recorded on a company's balance sheet. View historical data for Chosa Oncology AB and its competitors. Chosa Oncology AB's current Total Stockholders Equity is kr21.67 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Chosa Oncology AB stock overvalued right now?
Chosa Oncology AB (XSAT:CHOSA) has a current Total Stockholders Equity of kr21.67 Mil. The current Total Stockholders Equity is kr21.67 Mil. Chosa Oncology AB's overall GF Score™ is 32/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Stockholders Equity calculated?
Total Stockholders Equity is calculated from a company's financial statements. For Chosa Oncology AB (XSAT:CHOSA), the current Total Stockholders Equity is kr21.67 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Chosa Oncology AB Business Description

Address Scheeletorget 1, Medicon Village, Lund, SWE, 223 81
Chosa Oncology AB is a biotechnology company engaged in the research and development in immunotherapy on therapeutic cancer vaccines.
32GF Score

Get the complete analysis for XSAT:CHOSA

Total Stockholders Equity is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

kr0.74
Price